Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 919,048 | 486,425 | 1,575,794 | 1,213,656 | 815,337 |
| Depreciation Amortization | 67,119 | 29,635 | 101,360 | 41,814 | 26,282 |
| Income taxes - deferred | -158 | 4,263 | 113,384 | 93,589 | 39,804 |
| Accounts receivable | -183,951 | -141,022 | -138,034 | -162,026 | -115,322 |
| Accounts payable and accrued liabilities | 314,499 | 104,674 | -77,549 | -104,043 | -101,783 |
| Other Working Capital | -69,349 | 58,117 | -332,381 | -233,805 | -2,353 |
| Other Operating Activity | -627 | 63,419 | 426,508 | 404,227 | 340,249 |
| Operating Cash Flow | $1,046,581 | $605,511 | $1,669,082 | $1,253,412 | $1,002,214 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -49,601 | -106,467 | -1,172,376 | -1,061,722 | -724,923 |
| PPE Investments | -41,947 | -16,749 | -78,648 | -64,326 | -46,830 |
| Net Acquisitions | -6,768 | N/A | -46,443 | -46,443 | N/A |
| Purchase Of Investment | N/A | N/A | -5,000 | N/A | N/A |
| Investing Cash Flow | $-98,316 | $-123,216 | $-1,302,467 | $-1,172,491 | $-771,753 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -193 | -97 | -99,459 | -99,377 | -99,248 |
| Common Stock Issued | 135,564 | 65,480 | 243,427 | 186,350 | 148,487 |
| Common Stock Repurchased | -965,989 | -815,936 | -487,543 | -454,888 | -454,888 |
| Other Financing Activity | 77,426 | 60,831 | 172,592 | 85,279 | 68,861 |
| Financing Cash Flow | $-753,192 | $-689,722 | $-170,983 | $-282,636 | $-336,788 |
| Exchange Rate Effect | -43,560 | -37,775 | -43,553 | -30,164 | -8,032 |
| Beginning Cash Position | 968,086 | 968,086 | 816,007 | 816,007 | 816,007 |
| End Cash Position | 1,119,599 | 722,884 | 968,086 | 584,128 | 701,648 |
| Net Cash Flow | $151,513 | $-245,202 | $152,079 | $-231,879 | $-114,359 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,046,581 | 605,511 | 1,669,082 | 1,253,412 | 1,002,214 |
| Capital Expenditure | -41,947 | -16,749 | -78,648 | -64,326 | -46,830 |
| Free Cash Flow | 1,004,634 | 588,762 | 1,590,434 | 1,189,086 | 955,384 |